PURPOSE: To evaluate reader variability of white matter lesions seen on cranial sonographic scans of extreme low gestational age neonates (ELGANs). METHODS: In 1,452 ELGANs, cranial sonographic scans were obtained in the first and second postnatal weeks, and between the third postnatal week and term. All sets of scans were read independently by two sonologists. We reviewed the use of four diagnostic labels: early periventricular leucomalacia, cystic periventricular leucomalacia, periventricular hemorrhagic infarction (PVHI), and other white matter diagnosis, by 16 sonologists at 14 institutions. We evaluated the association of these labels with location and laterality of hyperechoic and hypoechoic lesions, location of intraventricular hemorrhage, and characteristics of ventricular enlargement. RESULTS: Experienced sonologists differed substantially in their application of the diagnostic labels. Three readers applied early periventricular leucomalacia to more than one fourth of all the scans they read, whereas eight applied this label to ≤5% of scans. Five applied PVHI to ≥10% of scans, while three applied this label to ≤5% of scans. More than one third of scans labeled cystic periventricular leucomalacia had unilateral hypoechoic lesions. White matter abnormalities in PVHI were more extensive than in periventricular leucomalacia and were more anteriorly located. Hypoechoic lesions on late scans tended to be in the same locations, regardless of the diagnostic label applied. CONCLUSIONS: Experienced sonologists differ considerably in their tendency to apply diagnostic labels for white matter lesions. This is due to lack of universally agreed-upon definitions. We recommend reducing this variability to improve the validity of large multicenter studies.
PURPOSE: To evaluate reader variability of white matter lesions seen on cranial sonographic scans of extreme low gestational age neonates (ELGANs). METHODS: In 1,452 ELGANs, cranial sonographic scans were obtained in the first and second postnatal weeks, and between the third postnatal week and term. All sets of scans were read independently by two sonologists. We reviewed the use of four diagnostic labels: early periventricular leucomalacia, cystic periventricular leucomalacia, periventricular hemorrhagic infarction (PVHI), and other white matter diagnosis, by 16 sonologists at 14 institutions. We evaluated the association of these labels with location and laterality of hyperechoic and hypoechoic lesions, location of intraventricular hemorrhage, and characteristics of ventricular enlargement. RESULTS: Experienced sonologists differed substantially in their application of the diagnostic labels. Three readers applied early periventricular leucomalacia to more than one fourth of all the scans they read, whereas eight applied this label to ≤5% of scans. Five applied PVHI to ≥10% of scans, while three applied this label to ≤5% of scans. More than one third of scans labeled cystic periventricular leucomalacia had unilateral hypoechoic lesions. White matter abnormalities in PVHI were more extensive than in periventricular leucomalacia and were more anteriorly located. Hypoechoic lesions on late scans tended to be in the same locations, regardless of the diagnostic label applied. CONCLUSIONS: Experienced sonologists differ considerably in their tendency to apply diagnostic labels for white matter lesions. This is due to lack of universally agreed-upon definitions. We recommend reducing this variability to improve the validity of large multicenter studies.
Authors: K C Kuban; E N Allred; O Dammann; M Pagano; A Leviton; J Share; M Abiri; D Di Salvo; P Doubilet; R Kairam; E Kazam; M Kirpekar; D L Rosenfeld; U M Sanocka; S M Schonfeld Journal: J Child Neurol Date: 2001-06 Impact factor: 1.987
Authors: Faith G Davis; Beatrice S Malmer; Ken Aldape; Jill S Barnholtz-Sloan; Melissa L Bondy; Thomas Brännström; Janet M Bruner; Peter C Burger; V Peter Collins; Peter D Inskip; Carol Kruchko; Bridget J McCarthy; Roger E McLendon; Siegal Sadetzki; Tarik Tihan; Margaret R Wrensch; Patricia A Buffler Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-03 Impact factor: 4.254
Authors: T Michael O'Shea; Karl C K Kuban; Elizabeth N Allred; Nigel Paneth; Marcello Pagano; Olaf Dammann; Lisa Bostic; Kara Brooklier; Samantha Butler; Donald J Goldstein; Gail Hounshell; Cecelia Keller; Susan McQuiston; Alice Miller; Steve Pasternak; Susan Plesha-Troyke; Joan Price; Elaine Romano; Katherine M Solomon; Amanda Jacobson; Sjirk Westra; Alan Leviton Journal: Pediatrics Date: 2008-09 Impact factor: 7.124
Authors: Elise Roze; Jorien M Kerstjens; Carel G B Maathuis; Hendrik J ter Horst; Arend F Bos Journal: Pediatrics Date: 2008-06-09 Impact factor: 7.124
Authors: Karl C K Kuban; Elizabeth N Allred; T Michael O'Shea; Nigel Paneth; Marcello Pagano; Olaf Dammann; Alan Leviton; Adré Du Plessis; Sjirk J Westra; Cindy R Miller; Haim Bassan; Kalpathy Krishnamoorthy; Joseph Junewick; Nicholas Olomu; Elaine Romano; Joanna Seibert; Steve Engelke; Padmani Karna; Daniel Batton; Sunila E O'Connor; Cecelia E Keller Journal: J Child Neurol Date: 2009-01 Impact factor: 1.987
Authors: Karl C K Kuban; Elizabeth N Allred; T Michael O'Shea; Nigel Paneth; Sjirk Westra; Cindy Miller; N Paul Rosman; Alan Leviton Journal: J Pediatr Date: 2009-06-24 Impact factor: 4.406
Authors: Alvaro Rea-Neto; Nazah Cherif M Youssef; Fabio Tuche; Frank Brunkhorst; V Marco Ranieri; Konrad Reinhart; Yasser Sakr Journal: Crit Care Date: 2008-04-21 Impact factor: 9.097
Authors: Kalpathy S Krishnamoorthy; Karl C K Kuban; T Michael O'Shea; Sjirk J Westra; Elizabeth N Allred; Alan Leviton Journal: J Child Neurol Date: 2010-08-19 Impact factor: 1.987